Proteja Sua Visão Com Nutrientes Review and Ads Breakdown

What Is Proteja Sua Visão Com Nutrientes

Proteja Sua Visão Com Nutrientes is best understood as the campaign concept or offer angle for a vision-support supplement presented in the transcript as Visio7 / Visioset. It is positioned as a new-generation eye health formula available in France and built for people who feel their vision is declining with age.

The format is a direct-response VSL. The viewer is told that supporting eye health can take less than 12 seconds per day, with no surgery, no eye exercises, and no special glasses. The supplement is described as a capsule product, with the transcript later mentioning a box of 60 capsules for one month.

The VSL says the product was created after months of research and development by Laboratoire Serenalp. Its main branded ingredient is FloraGlo, a lutein and zeaxanthin blend. The presentation frames FloraGlo as more powerful than ordinary eye nutrients because the active compounds are described as bioavailable and directly active in the eyes.

The product is aimed at older adults, especially people over 50 or 60, who worry about losing visual sharpness, struggling with screens, avoiding night driving, or becoming dependent on others. The message is not just about eyesight. It is about freedom, autonomy, and the fear of needing help with shopping, paperwork, dressing, or daily tasks.

The Problem It Targets

The VSL targets two main problems. The first is the alleged decline of lutein and zeaxanthin intake and concentration with age. The second is exposure to blue-violet light, which the presentation describes as an invisible ray that damages protective eye cells.

According to the presentation, people should consume 6 to 10 mg of lutein per day to maintain good eye health, but the VSL says many people consume far less, sometimes around 4 mg per day. It also claims that after age 60, lutein levels in the eyes collapse and may be divided by four over 20 years. The VSL frames this as one of the major factors behind vision loss.

The second villain is blue-violet light from sunlight, screens, smartphones, televisions, tablets, computer monitors, indoor bulbs, and ordinary daily environments. The transcript claims this light attacks the cells that protect the eyes from pollution, UV rays, smoke, pesticides, and dust. Once those cells are damaged, the VSL says the eyes become more vulnerable to external aggression.

This is where the emotional pressure intensifies. The presentation says destroyed vision cells cannot repair themselves and that the destruction is irreversible. It links this danger to feared age-related eye conditions such as DMLA and other serious eye problems. Again, these are claims made by the presentation, not independent medical conclusions in this review.

The practical pains are highly relatable: trouble reading small labels, fatigue while looking at screens, blurry vision, discomfort in low light, glare from headlights, and fear of losing the ability to drive. The VSL turns these small frustrations into signs of a bigger looming threat.

How Proteja Sua Visão Com Nutrientes Works

According to the VSL, Proteja Sua Visão Com Nutrientes works by supplying the eyes with concentrated nutrients that modern diets may not provide in sufficient amounts. The mechanism is built around carotenoids, antioxidants, and micronutrients that the presentation says support normal eye function and protection.

The hero mechanism is FloraGlo lutein and zeaxanthin. These two compounds are presented as carotenoids found naturally in foods like green vegetables, red fruits, carrots, spinach, broccoli, apricots, egg yolks, peppers, avocado, oranges, and grapes. The VSL says these nutrients help filter blue-violet light and act like an internal pair of sunglasses.

The VSL also claims that in 14 hours, lutein concentration in the eyes can increase by up to 126%. The transcript does not provide the full study citation behind that claim, so a careful reader should treat it as a presentation claim. Still, this number is a major persuasion point because it suggests fast biological activity.

The formula is then broadened beyond FloraGlo. Bilberry is included for anthocyanins, which the VSL connects to dark adaptation, eye fatigue, and computer-related dryness. Maritime pine bark is presented as a source of OPCs that help protect against UV rays, dust, pollution, smoke, and premature retinal aging. Vitamin B2 is positioned as vital for maintaining vision, while zinc is tied to normal vision and vitamin A transport. Vitamin E and vitamin B3 are added as complementary nutrients.

The overall mechanism is simple: feed the eyes the nutrients they allegedly lack, protect them from daily light and environmental stress, and support better visual comfort over time. The VSL repeatedly frames this as a non-invasive alternative to doing nothing while vision declines.

Key Ingredients and Components

The transcript does disclose a specific ingredient list, although it does not provide a full Supplement Facts panel with exact doses for every component. The named ingredients are FloraGlo lutein and zeaxanthin, bilberry, maritime pine bark, vitamin B2, zinc, vitamin E, and vitamin B3.

FloraGlo lutein and zeaxanthin are the centerpiece. The VSL says FloraGlo comes from a flower native to Mexico called Campazuchil, known in French as rose d'Inde, or marigold. The presentation claims a technological process makes the active compounds highly bioavailable and directly active in the eyes. The claimed benefit is filtering blue-violet rays and helping protect the retina.

Bilberry is the second major botanical. The VSL uses the famous Royal Air Force story, saying pilots were allegedly given bilberry jam during the Second World War to improve night vision. The presentation admits the story may have been used to hide radar from the Germans, but still argues that bilberry contains promising compounds called anthocyanins. It cites studies suggesting bilberry may support dark adaptation, visual function, dryness, and computer-related eye fatigue.

Maritime pine bark is included for OPCs, or oligomeric procyanidins. The VSL describes these molecules as ultra-protective and says they help defend against UV rays, dust, pollution, and smoke. It frames this as the third major asset of the formula.

Vitamin B2, also called riboflavin, is described as vital for maintaining good vision. The transcript says the formula includes 1.4 mg of vitamin B2, and it references a recommended intake range of 1.3 to 1.6 mg per day. The presentation connects inadequate B2 intake with increased cataract risk, though this should be read as the VSL's claim rather than a treatment statement.

Zinc is included because, according to the presentation, it helps transport vitamin A from the liver to the retina to produce melanin, supports normal vision, and is recognized by EFSA for maintaining normal vision. The VSL also claims zinc deficiency is common in adults because absorption worsens with age.

Finally, the formula includes vitamin E and vitamin B3. The presentation says vitamin E helps fight eye aging and reduce cataract risk, while vitamin B3 is framed as helping prevent glaucoma development. These are strong claims, and the transcript does not provide enough detail to verify the exact evidence behind them.

The VSL Hook and Story

The VSL's main hook is one of the strongest parts of the campaign: would you rather buy a new house or keep correct vision after 70, 80, or 85? It is designed to make vision feel priceless. A house is expensive, but eyesight is framed as more valuable than any asset.

From there, the story becomes darker. The viewer is told that relying on reading glasses may hide what is coming: cataracts, DMLA, glaucoma, and severe vision loss. The VSL paints a picture of an older person who cannot drive, cannot read, and cannot see the faces of loved ones. This is not a clinical opening; it is emotional problem agitation.

Then comes the relief: there is now a simple way to act on eye health in less than 12 seconds per day. This creates the classic contrast between a terrifying future and an easy daily action. The product becomes the bridge from fear to control.

The story also uses a two-villain structure. Villain one is the disappearance of mega natural protectors, especially lutein and zeaxanthin. Villain two is blue-violet light, which is said to attack the eyes through modern life: screens, phones, TVs, lamps, sunlight, and tablets. This makes the problem feel unavoidable and continuous.

The VSL then transitions into research. It cites the National Eye Institute, a large U.S. study, more than 80 clinics, and 4,000 participants. This shifts the tone from fear to authority. The viewer is no longer just scared; they are being told that scientists have found a nutrient-based answer.

Ads Breakdown

The ad angles behind this offer are easy to map from the transcript. The first is the independence angle. The campaign is not merely selling sharper sight. It is selling the ability to keep reading, driving, shopping, dressing, doing paperwork, and living without constant help.

The second angle is the blue-violet light danger angle. This is built for modern traffic sources because nearly everyone uses screens. The VSL says the harmful ray is present when you answer a WhatsApp message, read an email, watch TV, use a tablet, or look at a computer. That makes the ad broadly relevant.

The third angle is the 12-second daily solution angle. The presentation repeatedly says there is no surgery, no exercise, and no special glasses. This removes friction. The viewer does not have to learn a technique, buy equipment, or change their life. They just take capsules.

The fourth angle is the missing nutrient angle. The VSL says even people who eat correctly may not get enough lutein and zeaxanthin. This is persuasive because it removes blame from the viewer. The problem is not laziness; it is that modern intake is insufficient and age reduces eye nutrient concentration.

The fifth angle is the scientific discovery angle. The VSL references the National Eye Institute study, FloraGlo, Inserm, EFSA, bilberry research, glaucoma research, and vitamin research. These references create the feeling of a research-backed formula, even though the transcript does not provide enough detail to independently validate every claim.

The sixth angle is the launch scarcity angle. The product is said to be newly available in France, still at its launch price, and limited in quantity. The viewer is told the price will never be this low again and that stock may not last until the end of the week.

Psychological Triggers and Persuasion Tactics

The dominant trigger is fear of loss. Losing vision is framed as worse than losing money, property, or comfort. The VSL makes the consequences vivid: no driving, no reading, no seeing loved ones clearly, and no independence.

The second trigger is urgency. The viewer is told the product is available only recently, at a temporary launch price, and in limited quantities. This encourages immediate action rather than comparison shopping.

The third trigger is authority. The VSL cites Dr. Alicia Torilia, Inserm, the National Eye Institute, EFSA, ophthalmologists, researchers, and the R&D team at Laboratoire Serenalp. Whether each claim is fully proven or not, the rhetorical effect is to surround the offer with institutional credibility.

The fourth trigger is mechanism specificity. Instead of saying the product is simply good for the eyes, the VSL explains lutein, zeaxanthin, blue-violet light, anthocyanins, OPCs, riboflavin, and zinc. This gives the promise a technical backbone.

The fifth trigger is future pacing. The VSL asks the viewer to imagine reading supermarket labels, driving at night without glare, doing sewing or crafts, reading books, solving crosswords, and seeing road signs. These examples are concrete and emotionally meaningful.

The sixth trigger is price anchoring. Before revealing the stated price of 69 euros, the presenter says a formula like this could easily cost 100 to 200 euros per month. That makes 69 euros feel comparatively reasonable.

Scientific and Authority Signals

The VSL uses several scientific signals. The most important is the reference to a 2013 National Eye Institute study involving 4,000 men and women aged 50 to 85 and researchers from more than 80 American clinics. According to the presentation, formulations containing lutein and zeaxanthin were compared with other nutrient combinations.

The transcript claims that people with low dietary lutein and zeaxanthin who took the FloraGlo blend reduced cataract progression risk by 30%. It also says participants reduced advanced DMLA progression risk by 10%, and by 26% among those who consumed very little lutein and zeaxanthin in their diet. These are significant claims, but the VSL does not provide enough source detail for this review to independently confirm the exact interpretation.

The presentation also cites a 2015 study where 72% of participants taking FloraGlo reportedly felt less glare from bright light such as headlights. Another study is said to show improved contrast distinction after six months, and another with 25 participants allegedly showed faster image processing after four months.

For bilberry, the VSL cites three laboratory trials around dark adaptation, a two-year study involving 209 men and 123 women with glaucoma, and other studies suggesting 160 to 480 mg daily bilberry extract may reduce computer-related dryness and fatigue.

The authority section is persuasive, but not complete. A rigorous buyer would still want the full label, exact dosages, contraindications, finished-product testing, and links to the cited research.

What Real Buyers Say

The transcript includes four named testimonials: Muriel, Hugues, Luc, and Anne-Marie. These testimonials appear to discuss lutein or FloraGlo actives rather than necessarily the finished product alone.

Muriel says she has had glaucoma and macular degeneration for 25 years and that lutein contributed greatly to slow disease progression. She also says her doctor finds no change during regular visits. This is framed as a stability testimonial.

Hugues says he had always been nearsighted and noticed worse focusing after age 40, especially when looking at his phone or around the room. He reports headaches and says that after taking one tablet per day, he noticed a slight difference after one week. After three weeks, he says his eyes focused again and he no longer had headaches.

Luc says he took 40 mg per day for several years, that his macular degeneration did not progress, and that his ophthalmologist strongly recommended it. This is another disease-adjacent testimonial, so it should be interpreted cautiously and not as proof of a disease treatment effect.

Anne-Marie says she had flashing lights in her eyes for years, about three times per month, and that since taking lutein they stopped. She adds that her eyes seem the same.

These testimonials support the VSL's emotional message, but they are anecdotal. They do not replace clinical evidence, medical diagnosis, or advice from an eye-care professional.

The Offer / Pricing / Risk Reversal

The VSL states that one box of 60 capsules costs 69 euros and represents a one-month supply. Before revealing that price, it anchors the value by saying a product this complete and innovative could easily cost 100 to 200 euros per month.

The transcript also says the product is at a launch price for only a few more weeks and that the price will never again be as low as it is now. It adds that quantities are limited and claims stock may not remain by the end of the week.

The offer begins to mention a multi-month deal, including three months totally offered, but the transcript cuts off before the full promotion is explained. Because the provided source ends mid-sentence, this review cannot accurately describe the complete bundle.

No refund guarantee or formal risk reversal appears in the supplied excerpt. That is an important missing piece. A buyer would want to verify the guarantee, shipping terms, return policy, subscription terms, and full price before ordering.

Who This Is For (and Who It Isn't)

This offer is clearly written for adults who are worried about aging vision, especially people over 50 or 60. It may appeal to someone who struggles with screen fatigue, night glare, small print, low-light vision, or anxiety about future independence.

It is also aimed at people who already believe in nutritional support for eye health and are familiar with ingredients like lutein, zeaxanthin, bilberry, and zinc. The VSL spends significant time educating the viewer, so it is especially targeted at buyers who respond to scientific-sounding explanations.

It is not for someone looking for a proven cure for cataracts, glaucoma, AMD, or any diagnosed eye disease. The presentation references those conditions, but this review does not interpret the supplement as a treatment. Anyone with symptoms, diagnosed disease, sudden vision changes, flashes, eye pain, or major vision loss should consult an eye-care professional.

It is also not for people who dislike scarcity-based marketing. The VSL uses urgency, limited stock language, and launch-price pressure. Some buyers may find that persuasive; others may see it as a reason to slow down and verify details.

Frequently Asked Questions

What is Proteja Sua Visão Com Nutrientes?
It is a vision supplement campaign reviewed from the supplied VSL transcript. The formula itself is presented as Visio7 / Visioset from Laboratoire Serenalp.

What ingredients are mentioned?
The VSL names FloraGlo lutein and zeaxanthin, bilberry, maritime pine bark, vitamin B2, zinc, vitamin E, and vitamin B3.

Does it cure eye disease?
No cure is proven by the transcript. The presentation discusses cataracts, DMLA, and glaucoma, but consumers should treat those as marketing and educational claims, not as medical treatment claims.

How much does it cost?
The stated base price is 69 euros for a box of 60 capsules, described as a one-month supply.

What is FloraGlo?
According to the VSL, FloraGlo is a lutein and zeaxanthin blend extracted from marigold and positioned as highly bioavailable.

Is there a guarantee?
No guarantee is included in the provided transcript excerpt.

Who is the product for?
The VSL targets older adults worried about age-related vision decline, night driving glare, screen fatigue, and loss of independence.

Are the testimonials enough proof?
No. The testimonials are personal stories. They may be persuasive, but they do not prove that the supplement will produce the same outcome for other users.

Final Take

Proteja Sua Visão Com Nutrientes is a strongly built vision supplement VSL with a clear direct-response structure. It opens with fear, builds urgency around aging eyes and blue-violet light, introduces FloraGlo lutein and zeaxanthin as the unique mechanism, then expands the formula with bilberry, maritime pine bark, vitamin B2, zinc, vitamin E, and vitamin B3.

The strongest parts of the presentation are its specific mechanism, concrete lifestyle examples, research references, and emotionally resonant independence theme. The weakest parts are the aggressive disease-adjacent framing, incomplete offer disclosure in the provided transcript, missing guarantee details, and lack of full citations or finished-product clinical evidence.

For research purposes, this is a classic eye-health supplement offer: nutrient depletion plus blue-light danger plus simple daily capsule plus launch scarcity. The VSL is persuasive, but buyers should verify the full label, dosage, guarantee, medical suitability, and ordering terms before making a decision.

Disclaimer: This article is for research and educational purposes only. It is not medical, legal, or financial advice, and it is not affiliated with the product or its makers. Always consult a qualified professional before making health or financial decisions.